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Summary.- Follicular-phase (Day 11) plasma prolactin, and plasma and urinary
oestrogen levels of70 nulliparous nuns were compared with those of80 oftheir sisters,
of whom 62 were parous. The nuns and their nulliparous sisters did not differ sig-
nificantly in their prolactin and oestrogen levels. No differences in plasma oestrogens
or urinary oestriol ratio were found between the parous and the nulliparous women.
However, the mean prolactin level of the nuns and their nulliparous sisters was 3500
higher than that of the parous women in the sample taken 13 h after rising (P<
0-0005), and 24% higher (P <0.01) in the 2nd sample taken 2 h later. The elevation
was independent of age, weight, and age at menarche. Age at first full-term preg-
nancy, at least up to the age of 30, and second or subsequent full-term pregnancies
had no further effect on prolactin level. This study suggests that the effect of early
first full-term pregnancy in lowering breast cancer risk may be mediated, at least
in part, by permanently lowering the level of circulating prolactin.
ONE OF THE MOST STRIKING breast-
cancer risk factors is age at first full-term
pregnancy (FFTP): women whose FFTP
is before the age of 20 have less than half
the breast-cancer risk of nulliparous
women (MacMahon et al., 1973). Two
theories have been proposed to "explain"
how this protective effect of early FFTP
is brought about. Cairns (1975) theorized
that early FFTP would effectively reduce
the number of susceptible breast "stem"
cells, while Cole et al. (1976) proposed that
the protective effect may be due to a
change in the "urinary oestriol ratio".
There is no evidence available to either
support or refute Cairns's hypothesis, but
there is some evidence that early FFTP
does increase the urinary oestriol ratio
(Cole et al., 1976; Trichopoulos et al.,
1980).
Prolactin may also play a key role in
determining risk of breast cancer (Hill
et al., 1976; Malarkey et al., 1977; Pike
et al., 1977; Welsch & Meites, 1978) and
we were struck by the finding ofVekemans
& Robyn (1975a) in a cross-sectional
study that prolactin levels decreased after
age 25 in women but not in men. If this
decrease with age in women is due to
pregnancy, this prolactin change may be a
critical part of the protective effect of
early FFTP.
In this paper we describe our results in
comparing the plasma prolactin, and plas-
ma and urinary oestrogen levels of nulli-
parous and parous women aged 20-40 in
California.
METHODS
With the cooperation of a number of
Catholic orders in California, we identified
Caucasian nuns aged 20-39, who had never
been pregnant and who had at least one sister
aged 20-39 residing in the continental U.S.
We excluded nuns who had had uterine
(excluding D&C) or ovarian surgery. We also
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excluded nuns who wiere not menstruating,
or who had used oral contraceptives (OCs)
or other oestrogens in the preceding 18
inonths. Seventy such nuns agreed to par-
ticipate in the study. We then attempted to
recruit to the study all the sisters of these
nuns, w%ho were either parous and at least 2
years past lactation, or nulliparous with less
than 1 year of life-time oestrogen use. We
again excluded women who had had uterine
(excluding caesarian section) or ovarian sur-
gery, or who were not menstruating, or who
had used OCs or other oestrogens in the
preceding 18 months. Eighty such sisters
agreed to participate (62 parous and 18
nulliparous).
All women wAere interviewed by telephone
by V.R.G. The questionnaire requested
information on height, weight, menstrual
and reproductive history, and prior and
current use of all hormones. On completion
of the interview the participant was asked to
call back on the first day of her next men-
strual period to arrange for the collection of
blood and urine specimens.
Two follicular-phase (Day 11) blood speci-
mens were drawn from each participant. The
first specimen was collected between 08:00
and 09:30 and at least - h after the subject
arose; the second specimen was drawn 2 h
after the first. An overnight (12h) urine
specimen wAas collected ending at 08:00 on
the morning when the blood sample w%,as
taken.
Each blood specimen was collected into
10ml tubes containing EDTA. After centri-
fugation, the plasma was separated and stored
in several aliquots at -20°C. Coded samples
ofplasma were sent in dry ice to Dr D. Mayes
at Endocrine Sciences Laboratory, Tarzana,
California, where prolactin, oestrone (pE ),
and oestradiol (pE2) were measured by radio-
immunoassay. The 2 plasma samples from
the same individual were pooled for the pEl
and pE2 measurements.
The urine was treated with 15 ml of 200%
acetic acid, divided into 25ml aliquots, and
stored at -20°C. Aliquots of urine were
coded and air-freighted frozen in dry ice to
Melbourne, where urine levels of oestrone
(uEl), oestradiol (uE2), and oestriol (uE3)
were measured by J.B.B., using a method
involving the use of spectrophotofluorimetry
and internal radioactive standards (Brown
et al., 1968). Urine hormone concentrations
were converted into absolute amounts by
multiplying the concentration by the total
volume ofurine collected.
All hormone levels were transformed to
logarithmic values for statistical analysis.
If, for any variable, the information on an
individual wNas not know,n, that individual
was excluded from the relevant analysis.
Crude differences in mean values were tested
for statistical significance by the non-para-
metric Mann-Whitney rank test. Standard
regression techniques were used to analyse
the relationship of hormone levels to other
variables, such as age, and to test for "adjus-
ted" mean values. All statistical significance
levels quoted (P values) are 1-sided unless
otherwise stated.
RESULTS
Table I presents the mean values of a
number of factors for the nuns, and the
parous and nulliparous sisters. The parous
sisters were divided into two groups based
on their history of oestrogen use. The
rationale was to separate out the effect,
if any, of past exogenous oestrogen on the
levels of prolactin and oestrogen. The 4
groups of women were similar in mean
height, weight, and age at menarche.
For the 2 groups of parous sisters, the
mean age at first full-term pregnancy
(FFTP) and the mean number ofpregnan-
cies were about the same. Four nuns
reported having taken oral contraceptives
(OCs) for menstrual irregularities for a
mean duration of 7 months. Ninety-six
per cent of parous sisters who reported a
year or more of past oestrogen use had
used OCs for a mean duration of 4 years.
Mean ages at first use were about the
same for all OC users in the 4 groups.
No statistically significant differences
were found between the 4 groups of
women in terms of seeking treatment for
amenorrhoea, menstrual irregularity, pro-
fuse menses, endometriosis, fibroids or
galactorrhoea. The mean length of the
cycle during which specimen collection
took place was 2 days shorter in the parous
than in the nulliparous women (P = 0 05).
Ninety-five per cent of parous women
claimed to have had regular cycles in the
6 months preceding specimen collection,
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TABLE I.-Characteristics of nuns and their sisters
Characteristic
No. of women
Age at interview
Age at menarche
Age at FFTP
Cycle length: (days)
% Regular cycle
Current
High school graduation
% OC use ever
Total No. of months
(1)
Nuns
70
34-1
12-2
31-3
84
81
6
6-8
(2) (3)
Parous sisters
oestrogen use
< I year >1 year
35 27
32-5 34-1
12-6 12-7
22-4 22-7
29-2 29-3
(4)
Nulli-
parous
sisters
18
27-8
12-5
31-6
(1+4)
Nulli-
parous
88
32-8
12-3
31-3
(2+3)
Parous
62
33-2
12-7
22-5
29-2
94 96 89 85 95
79 78 78 80 78
71 96 39 13 82
5-8 50-3 5-0 5-3 28-5
* Comparison of nulliparous and parous.
t X2 test.
t As recorded for cycle in which sample was drawn.
§ Mann-Whitney rank test.
TABLE II.-Geometric mean levels ofplasma and urinaryhormones ofnuns and their sisters
Hormonet
Plasma
(2) (3)
Parous sisters
oestrogen use
(1)
Nuns < I year >1 year
Prolactin (1)t (ng/ml) 23-5
Prolactin (2) } f(ng/ml) 15-4
El(1i2}(ng/100ml) 8-2
Urine (jg/12 h)
El
E2
E3
E3/(E1 +E2) =ER
(4)
Nulli-
parous
sisters
(1+4)
Nulli-
parous
(2+3) 1-sided
Parous P*
17-0 16-6 19-7 22-7 16-8 0-0004
13-1 11-5 15-4 15-4 12-4 0-006
7-7 8-2 7-7 8-1 7-9 0-32
10-6 12-9 12-8 12-0 11-7 0-32
4-3 4-0 4-1 4-3 4-3 4-0 0-25
2-2 2-0 2-2 2-1 2-2 2-1 0-30
4-8 4-4 5-0 4-8 4-8 4-6 0-46
0-73 0-73 0-79 0-74 0-73 0-75 0-42
* Comparison of nulliparous and parous, Mann-Whitney rank test.
t El, oestrone; E2, oestradiol; E3, oestriol.
t (1) = 1st sample, (2) =2nd sample.
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FIGURE.-Scatter plot of loge (prolactin)
values in nulliparous (NP) and parous (EP)
women.
compared to 85% ofthe nulliparous group
(P=0-05). The 2 groups responded simi-
larly, however, when asked if their cycle
was regular at the time of high-school
graduation. There was no difference in
response concerning the number of days
of menstrual flow either currently or at
the time of high-school graduation.
The hormone results from the blood and
urine specimens are shown in Table II.
Four of the 70 nuns but none of their
sisters had passed their 40th birthday by
the time of sample collection. The mean
time from rising to bleeding was 15 min
longer for the nulliparous women (115 vs
100 min, P=0-02). This was due to the
nulliparous womenrising earlier. Wefound
1-sided
P*
0-35§
0-13§
0-05§
0-05t
0-46t
E
N,
0 c
0 a-
A.
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TABLE III.-Geometric mean levels of plasma (p) and urinary (u) hormones, by age, of
nulliparous and parous women
Nulliparous
( ~~~~~A
< 30 30-34
22 24
20-3 23-6
15-0 15-6
7-4 7-7
9-2 10-3
3-7 4-2
1 8 2-0
3-5 4-6
0-64 0 74
35+
42
23-6
15-5
8-8
15-2t
4-8
2-7t
5-8t
0-78
Parous
< 30 30-34 35+
14 21 26
14-6 18-3 16-4
14-2 12-2 11-8
6-5 7-2 9-4t
8-3 11-1 14-4t
3-8 30 5-3t
1-9 1-5 2.9t
3-7 3-6 6-3t
0-64 0-81 0-76
* (1) = 1st sample, (2) = 2nd sample.
t P < 0 05, for trend.
little difference between the 2 parous
sister groups, or between the nuns and
their nulliparous sisters. However, al-
though there was a large amount of over-
lapping of results (Figure), we found
highly significant differences in mean pro-
lactin levels from both plasma samples
between the parous and nulliparous
women. The mean prolactin level in the
nulliparous women was 35% higher (P=
0.0004) for the 1st sample and 24% higher
(P = 0 006) for the 2nd sample. The higher
level ofprolactin in the nulliparous women
was maintained across all age groups
(Table III). Similar results were obtained
when we adjusted for possible effects of
weight and age at menarche on prolactin
level. There was no statistically significant
relationship between prolactin level and
age at FFTP; however, only 7 of the 62
parous women had their FFTP after the
age of 25. There was no effect on prolactin
level of second or subsequent full-term
pregnancies. There was little difference
between the nulliparous and the parous
women in the relationship between the
level of prolactin and time since rising,
the prolactin levels falling slightly more
sharply for the parous than for the nulli-
parous.
There was no significant difference in
the level ofcirculating oestrone and oestra-
diol among the parous women. There was
a positive correlation between the level of
plasma and urinary oestrogens and age
(Table III). The increase was most pro-
nounced for pE2. In nulliparous women
there was a 65% increase in mean pE2
between women aged under 30 and those
aged over 35; for the parous women the
increase in pE2 was 73% between these
two age groups. Similar results were
obtained when differences in possible con-
founding factors such as weight and age
at menarche were adjusted for.
There were 35 nun-parous-sister pairs
in which the sisters had not taken oestro-
gens for a year or more. A matched
analysis of just these pairs gave similar
results to the unmatched analysis pre-
sented above.
DISCUSSION
Our data clearly demonstrate that a
woman's plasma prolactin level may be
permanently lowered after her first full-
term pregnancy (FFTP). We found no
evidence that the prolactin level is
further lowered by subsequent births, nor
that it is associated with age at first
delivery, at least up to age 30. This effect
of FFTP could explain the decrease in
prolactin levels in women with age, up to
about age 35, noted by Vekemans &
Robyn (1975a) but it does not explain
why they observed a steady decrease
even up to age 65.
This study thus suggests that the pro-
tective effect of early FFTP may be
mediated, at least in part, by permanently
lowering the circulating level of prolactin.
The lack ofdecrease in prolactin level with
No. of women
Prolactin (1)*
Prolactin (2)*
pEl
pE2
uEl
uE2
uE3
ER
829830 M. C. YU, V. R. GERKINS, B. E. HENDERSON, J. B. BROWN AND M. C. PIKE
subsequent full-term deliveries is consis-
tent with the fact that such deliveries do
not further lower breast-cancer risk
(MacMahon et al., 1973).
Epidemiological data have shown that
a woman whose first delivery occurs after
age 35 years is at a higher risk of breast
cancer than a nulliparous women of the
same age (MacMahon et al., 1973). The
reason for this is not known, but Hill et al.
(1976) have reported a large increase in
prolactin level in women whose first preg-
nancy occurred after 35 years ofage, when
compared to women of comparable age
or parous women 20-35 years of age
(whether this increase was due to the
inclusion of a few women who had just
stopped lactating is not clear from the
paper). Our study population lacks women
in this category to test whether they
indeed have elevated prolactin levels.
Further study of this group of women is
needed.
Serum prolactin shows a marked cir-
cadian rhythm, with peak values in the
very early morning and a rapid decline
thereafter (see Vekemans & Robyn,
1975b, and references therein). We have
implicitly assumed in the discussion above
that our finding of decreased plasma pro-
lactin levels in parous women at 08:30
and 10: 30 reflects a decrease in both peak
levels and daily integrated levels. This
may not be true: for example, a shift in
the circadian rhythm, such that nulli-
parous women had a later peak than
parous women, could possibly produce the
observed results without implying that
either peak levels or daily integrated levels
were any higher in nulliparous women.
The only way in which this could defi-
nitelybeshown not to be the casewould be
to carry out multiple (or continuous)
sampling over the 24 h. Such procedures
are extremely difficult to carry out in
"normal" subjects and we know of no
evidence to suggest that our implicit
assumption is not correct. Vekemans &
Robyn (1975b) showed that women taking
ethinyloestradiol (400 ,ug/day) have raised
prolactin levels at all times ofthe day, but
published data on "normal" subjects
relating peak and 24h integrated values to
single morning samples is lacking, and
would be most valuable.
Cole et al. (1976) and Trichopoulos et al.
(1980) reported a high urinary oestriol
ratio (ER) in young parous women com-
pared to nulliparous women of the same
age. Our data do not, however, support
their ER hypothesis. We found no differ-
ence in ER between the parous and the
nulliparous women even after controlling
for the possible variation of ER with
age, weight and age at menarche. We
furthertestedtheirfindings bydividingour
women into groups most comparable to
theirs: (1) nulliparous, (2) parous with age
at FFTP under 25, (3) parous with age at
FFTP age 25 or over. There was almost
no difference in ER between the groups
(P=0.96). Cole et al. (1976) reported that
"in the follicular phase, the youngest
(aged 19-23) parous women had an
oestriol ratio 40% higher than, and sig-
nificantly different from, the ratios of all
other groups which were otherwise quite
similar". In the light of our findings, it
appears that the high ER in these young
women might be only a transient pheno-
menon related to pregnancy at an early
age.
Age was found to correlate positively
with plasma and urinary levels of oestro-
gens. England et al. (1974) also found an
increase in plasma oestradiol levels with
increasing age in normal premenopausal
women, but the increase was restricted to
the luteal phase. Further data are clearly
required.
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